Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

DBCOND0057506Respiratory Tract Diseases

Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Moderate to Severe COPD · Moderate to Very Severe Chronic Obstructive Pulmonary Disease · moderate, severe Chronic Obstructive Pulmonary Disease (COPD)
Classified under
Indicated drugs

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In